Mis S-S Bypass Versus Adhesion Lysis in PTS
Syringomyelia · Spinal Cord Injury
What this study involves
The registry does not currently label this study as recruiting. Ask about its status before planning a screening visit.
- Study type
- Interventional
- Phase
- Not applicable
- Age range
- 18 years - 80 years
- Sex eligible
- All sexes
- Healthy volunteers
- Not accepted
- Participants
- 80 Actual
These are starting points, not an eligibility decision. The research team must review the full requirements.
About the research
To determine whether A novel minimally invasive Subarachnoid-Subarachnoid (S-S) Bypass results in better patient outcomes with improved quality of life and fewer complications compared to intradural adhesion lysis in individuals with posttraumatic Syringomyelia.
Read the full description
Recently, our team was the first to report in the Journal of Neurosurgery: Spine (JNSSPINE) a minimally invasive subarachnoid-subarachnoid cerebrospinal fluid bypass technique for the treatment of post-traumatic syringomyelia. This novel approach has attracted considerable international attention and achieved favorable clinical outcomes for the treatment of post-traumatic syringomyelia. To establish high-level evidence, participants with posttraumatic Syringomyelia will be randomized to either have A novel minimally invasive Subarachnoid-Subarachnoid (S-S) Bypass or intradural adhesion Lysis. The participant will then return to the neurosurgeon's office at the following time points which are consistent with standard of care practice: 3-6, 12±2months. At these visits, the clinician will complete a physical exam and the participant will report on the prognosis of symptoms and complete questionnaires. A spine MRI will be performed 3-6, 12±2months after the surgery.
The multicenter design, target sample size, assessor masking, eligibility criteria, and outcome hierarchy described in this record were specified in the ethics-approved protocol before enrollment of the first participant. The initial public registry entry did not fully reflect the finalized protocol. The registry record was corrected on 2026-11, before database lock and before any unblinded between-group analysis, to align it with the prospectively approved protocol.
Who may be able to participate?
The list below is the sponsor’s full registry wording. It can include conditions, prior treatment, test results and other requirements. A match in search does not mean you qualify.
Inclusion Criteria:
- History of traumatic spinal cord injury
- Evidence of progressive neurological deficit and/or pain syndrome
- MRI showing a syringomyelia due to spinal cord injury
- Both myelography and MRI show extensive arachnopathy exceeding 2 spinal segments in length
Exclusion Criteria:
- Chiari malformation
- Myelomalacia
- Subarachnoid cyst
- Syringomyelia due to other spinal diseases (such as degenerative spinal disease)
- Marked spinal kyphosis
Treatment, groups and participation
The registry may describe treatments and study duration without a complete visit calendar. Ask the study team for the exact schedule, procedures, risks, costs and alternatives. Keep your usual care plan unless your treating clinician tells you otherwise.
- Assignment
- Random assignment
- Masking
- Single masked
A novel minimally invasive Subarachnoid-Subarachnoid (S-S) Bypass
After dissections of the normal arachnoid mater at the cephalic and caudal sites, 2 tubes made of medical grade silicone (internal diameter 1.1 mm, external diameter 2.5 mm; Sophysa Systems Corp.) were inserted into the cephalic and caudal ends of the normal subarachnoid space.
The tubes were only inserted into the normal subarachnoid space, with the remaining portions running subcutaneously.
Procedure: A novel minimally invasive Subarachnoid-Subarachnoid (S-S) Bypass
Intradural Adhesion Lysis
The dura is opened sharply, exposing the spinal cord. After microsurgical dissection adhesion, the dura is sewn closed with a dural graft.
Procedure: Intradural Adhesion Lysis
A novel minimally invasive Subarachnoid-Subarachnoid (S-S) Bypass PROCEDURE
After dissections of the normal dura mater at the cranial and caudal sites, a tunneling device (a passer) was used to create a subcutaneous tunnel. Two tubes made of medical grade silicone (internal diameter 1.1 mm, external diameter 2.5 mm; Sophysa Systems Corp.) were inserted into the cranial and caudal ends of the normal subarachnoid space.
Under the surgical microscope, the normal dura was incised bilaterally approximately 3 mm on either side of the midline at the cranial end. The arachnoid was opened, with the proximal ends of the drainage tubes inserted approximately 5 cm into the normal subarachnoid space, with the remaining portions running subcutaneously. No loosening operations were performed at the site of injury. The incisions were sutured layer by layer
Intradural Adhesion Lysis PROCEDURE
Intradural spinal cord Adhesion Lysis
What researchers are measuring
Outcome measures describe what is being studied. They are not proof that a treatment works.
Primary measures
The Number of Patients With Clinical Improvement
Time frame: 3-6, 12±2 months
Number of patients who experienced improvement in clinical or neurological symptoms-such as; sensory dysfunction (numbness, paresthesia, or sensory loss), neuropathic pain, motor weakness, gait impairment, bowel and bladder dysfunction, and spasticity.
Secondary measures
change of the volume of syrinx,
Time frame: 3-6, 12±2 months
defined as change in length, maximal cross-sectional diameter, or both.
Klekamp and Sammi syringomyelia scale
Time frame: 3-6, 12±2 months
for evaluating the spinal cord function, Each item is scored on a scale from 0 to 5, with 5 representing the best possible functional status.
modified Japanese Orthopaedic Association Scores (mJOA)
Time frame: 3-6, 12±2 months
Motor function, sensory, bladder function;for evaluating the spinal cord function;0-17, higher scores mean a better outcome
xuanwu syringomyelia scale
Time frame: 3-6, 12±2 months
for evaluating the spinal cord function, for evaluating the spinal cord function;0-18, higher scores mean a worse outcome
complication
Time frame: 3-6, 12±2 months
various complication, such as fever, csf fistula
ASIA score
Time frame: 3-6, 12±2 months
American Spinal Injury Association(ASIA) Score for evaluating the spinal cord function, degree of the spinal cord function, motor1-100, sensory 1-224, higher scores mean a better outcome
VAS score
Time frame: 3-6, 12±2 months
VAS Score for evaluating the degree of the pain, VAS 0-10, higher scores mean a worse outcome
Review the complete result tables and limitations in the official record.
Open official results ↗Research locations (1)
The overall study status and a local site’s status can differ. Confirm that location’s availability before traveling.
1 locations
Fengzeng JianBeijing, Beijing Municipality, ChinaStatus unknown
Study team and timeline
- Lead sponsor
- Xuanwu Hospital, Beijing
- Study start
- Jun 25, 2025 Actual
- Primary completion
- Jun 25, 2027 Estimated
- Study completion
- Jun 25, 2027 Estimated
- First posted
- Apr 19, 2024 Actual
- Last updated
- Nov 10, 2026 Actual
Official study contacts
No central contact is listed. Check the locations and the official record.
Official study title
A Novel Minimally Invasive Subarachnoid-Subarachnoid (S-S) Bypass Versus Adhesion Lysis in Post-traumatic Syringomyelia
Ask Wellness Clinical Research
Your message goes to WCR, including when this study is run by another organization. WCR may offer general guidance but may not operate this trial, have access to its team or be able to enroll you.
Source: ClinicalTrials.gov API v2. Information is submitted by sponsors and investigators. NLM does not approve the safety or science of all listed studies. Registry disclaimer.
Retrieved: Nov 12, 2026 · Last registry update: Nov 10, 2026
